Bangwei Cao

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Shukui Qin, Li Qiu, Shanzhi Gu et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 254 citations

Medicine, Oncology, Pharmacotherapy +10

Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathway

Jing Yu, Xiaoyun Zhu, Xin Qi et al. · Toxicology Letters · 2013 · 103 citations

Life Sciences, Cell Biology, Physiology +17

Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients

Lei Zhao, Jing Yu, Jing Wang et al. · Journal of Cancer · 2017 · 82 citations · Full text

Medicine, Molecular Biology, Oncology +17

LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China

Bangwei Cao, Xiuyun Tian, Yong Li et al. · Carcinogenesis · 2005 · 81 citations

Life Sciences, Genetics, Oncology +17

Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer

Lei Zhao, Lai-Han Leung, Jing Wang et al. · BMC Pulmonary Medicine · 2017 · 78 citations · Full text

Medicine, Oncology, Epidemiology +15